- Investing Ideas
- /
- U.S. Top Stock Picks from Analysts
U.S. Top Stock Picks from Analysts
Results
1417
Companies which are more than 50% undervalued based on analyst price target.
1,417 companies
Relmada Therapeutics
Market Cap: US$12.1m
Operates as a clinical-stage biotechnology company in the United States.
RLMD
US$0.42
7D
14.9%
1Y
-88.1%
S&W Seed
Market Cap: US$11.9m
An agricultural company, engages in breeding, growing, processing, and sale of alfalfa and sorghum seeds in North and South America, Australia, and internationally.
SANW
US$5.60
7D
0.9%
1Y
-27.5%
SideChannel
Market Cap: US$11.8m
SideChannel, Inc. identifies, develops, and deploys of v solutions in North America.
SDCH
US$0.047
7D
-3.5%
1Y
-21.8%
Bionano Genomics
Market Cap: US$11.6m
Provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.
BNGO
US$3.84
7D
-5.3%
1Y
-93.3%
Affimed
Market Cap: US$11.5m
A clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany.
AFMD
US$0.69
7D
-28.6%
1Y
-87.0%
Cellectar Biosciences
Market Cap: US$11.4m
A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.
CLRB
US$0.25
7D
-8.6%
1Y
-91.9%
Kairos Pharma
Market Cap: US$11.4m
A clinical-stage biopharmaceutical company, develops therapeutics for cancer patients.
KAPA
US$0.68
7D
-16.3%
1Y
n/a
Minerva Neurosciences
Market Cap: US$11.3m
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.
NERV
US$1.61
7D
-5.3%
1Y
-32.6%
TruGolf Holdings
Market Cap: US$11.2m
Through its subsidiary, engages in the development and sale of indoor golf simulator hardware under the TruGolf Nevada brand for residential and commercial markets in the United States.
TRUG
US$0.25
7D
-11.7%
1Y
-82.9%
Cardio Diagnostics Holdings
Market Cap: US$11.1m
Develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
CDIO
US$0.19
7D
-56.7%
1Y
-79.6%
United Maritime
Market Cap: US$11.0m
A shipping company, offers seaborne transportation services worldwide.
USEA
US$1.21
7D
2.2%
1Y
-54.3%
SeaStar Medical Holding
Market Cap: US$10.8m
A commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.
ICU
US$1.25
7D
-3.1%
1Y
-87.6%
Oxbridge Re Holdings
Market Cap: US$10.7m
Through its subsidiaries, provides specialty property and casualty reinsurance solutions.
OXBR
US$1.65
7D
-8.1%
1Y
24.1%
Orangekloud Technology
Market Cap: US$10.7m
An investment holding company, provides enterprise application development services in Singapore, Indonesia, Malaysia, the United States, and internationally.
ORKT
US$0.47
7D
-6.7%
1Y
n/a
Plus Therapeutics
Market Cap: US$10.5m
A clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.
PSTV
US$0.66
7D
1.9%
1Y
-69.4%
STRATA Skin Sciences
Market Cap: US$10.4m
A medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.
SSKN
US$2.46
7D
-6.5%
1Y
-34.4%
Athira Pharma
Market Cap: US$10.4m
Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.
ATHA
US$0.25
7D
-11.7%
1Y
-88.0%
Ekso Bionics Holdings
Market Cap: US$10.3m
Designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
EKSO
US$0.43
7D
-11.6%
1Y
-68.4%
Abpro Holdings
Market Cap: US$9.9m
A biotechnology company, provides antibody therapeutics for cancer related issues.
ABP
US$0.20
7D
-13.0%
1Y
-98.2%
Jet.AI
Market Cap: US$9.9m
Engages in the development and operation of private aviation platforms.
JTAI
US$4.49
7D
8.7%
1Y
-97.1%
LM Funding America
Market Cap: US$9.9m
Operates as a cryptocurrency mining and specialty finance company.
LMFA
US$1.90
7D
10.8%
1Y
-18.1%
Kiora Pharmaceuticals
Market Cap: US$9.8m
A clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases.
KPRX
US$3.25
7D
-2.0%
1Y
-25.7%
Pharma-Bio Serv
Market Cap: US$9.7m
Operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
PBSV
US$0.50
7D
11.7%
1Y
-33.3%
Sensei Biotherapeutics
Market Cap: US$9.5m
A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.
SNSE
US$0.36
7D
-15.1%
1Y
-76.2%
Talphera
Market Cap: US$9.4m
A specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.
TLPH
US$0.54
7D
0.9%
1Y
-46.8%
Aqua Metals
Market Cap: US$9.2m
Focuses on reinventing metals recycling activities with its patented AquaRefining technologies.
AQMS
US$0.97
7D
-21.4%
1Y
-89.3%
Evaxion Biotech
Market Cap: US$9.2m
A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.
EVAX
US$1.49
7D
-5.1%
1Y
-92.0%
Capstone Holding
Market Cap: US$9.1m
Engages in the distribution of masonry stone products in the Midwest and Northeast United States.
CAPS
US$1.75
7D
-6.9%
1Y
-62.2%
Aprea Therapeutics
Market Cap: US$9.1m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.
APRE
US$1.62
7D
-12.4%
1Y
-71.0%
Carisma Therapeutics
Market Cap: US$9.0m
A biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States.
CARM
US$0.19
7D
-23.7%
1Y
-87.1%
Splash Beverage Group
Market Cap: US$8.9m
Engages in the manufacturing, distribution, marketing, and sale of various beverages in the United States.
SBEV
US$5.77
7D
-26.2%
1Y
-53.5%
VerifyMe
Market Cap: US$8.9m
Provides traceability and customer support services through software and process technology.
VRME
US$0.77
7D
3.7%
1Y
-56.5%
Dogwood Therapeutics
Market Cap: US$8.7m
A development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders.
DWTX
US$4.56
7D
-9.2%
1Y
-48.6%
Neuphoria Therapeutics
Market Cap: US$8.7m
A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.
NEUP
US$5.01
7D
-0.9%
1Y
n/a
BioXcel Therapeutics
Market Cap: US$8.6m
Together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States.
BTAI
US$1.53
7D
-14.0%
1Y
-95.4%
Intensity Therapeutics
Market Cap: US$8.6m
A late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States.
INTS
US$0.54
7D
-5.9%
1Y
-86.5%